24.01.2023Refining risk prediction by addressing residual thrombotic risk in patients with acute coronary syndromes: the A/I-ACS study

Congratulations to Dr. Simon Kraler for receiving competetive funding for his project entitled 'Refining risk prediction by addressing residual thrombotic risk in patients with acute coronary syndromes: the A/I-ACS study' recently granted by the Novartis Foundation for medical-biological Research.